Jump Financial LLC Trims Stake in Braskem S.A. (NYSE:BAK)

Jump Financial LLC lowered its holdings in shares of Braskem S.A. (NYSE:BAK) by 86.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,400 shares of the company’s stock after selling 112,923 shares during the period. Jump Financial LLC’s holdings in Braskem were worth $67,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. JPMorgan Chase & Co. boosted its stake in Braskem by 876.1% during the third quarter. JPMorgan Chase & Co. now owns 5,427 shares of the company’s stock worth $40,000 after acquiring an additional 4,871 shares in the last quarter. R Squared Ltd bought a new stake in Braskem during the fourth quarter worth about $44,000. Blue Trust Inc. boosted its stake in Braskem by 2,510.3% during the fourth quarter. Blue Trust Inc. now owns 13,130 shares of the company’s stock worth $51,000 after acquiring an additional 12,627 shares in the last quarter. Signaturefd LLC bought a new stake in Braskem during the fourth quarter worth about $53,000. Finally, HighTower Advisors LLC boosted its stake in Braskem by 19.4% during the fourth quarter. HighTower Advisors LLC now owns 19,213 shares of the company’s stock worth $74,000 after acquiring an additional 3,126 shares in the last quarter.

Analyst Upgrades and Downgrades

Separately, Scotiabank downgraded shares of Braskem from a “sector outperform” rating to a “sector perform” rating in a research note on Monday, March 3rd.

Braskem Stock Performance

Shares of NYSE BAK opened at $3.94 on Tuesday. The firm’s 50 day moving average price is $3.70 and its 200-day moving average price is $4.48. The company has a market cap of $1.57 billion, a PE ratio of -1.11 and a beta of 1.80. Braskem S.A. has a 52-week low of $2.85 and a 52-week high of $9.21.

Braskem (NYSE:BAK) last issued its quarterly earnings data on Thursday, February 27th. The company reported ($0.39) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.38) by ($0.01). The company had revenue of $3.28 billion for the quarter, compared to the consensus estimate of $3.52 billion. Braskem had a negative net margin of 9.88% and a negative return on equity of 439.59%. On average, analysts forecast that Braskem S.A. will post -0.77 earnings per share for the current fiscal year.

Braskem Company Profile

Braskem SA, together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins.